Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • ESG
  • News & Media
  • Contact
  • Menu Menu

๐—š๐—ฎ๐˜๐—ฒ๐Ÿฎ๐—•๐—ฟ๐—ฎ๐—ถ๐—ป ๐˜๐˜‚๐—ฟ๐—ป๐˜€ ๐Ÿฑ!

News

Last week, we came together โ€” team members, collaborators, advisors, funding and institutional partners and supporting entitiesโ€ฆthe Gate2Brain family at large โ€” to celebrateย five yearsย of science, passion, and purpose.
What began as a bold idea has grown into a vibrant project that continues to push the boundaries of drug delivery to the brain.

These first five years have been filled with milestones, lessons, and relentless commitment to our mission: to improve patientsโ€™ quality of life by enabling effective treatments to reach their target, beyond barriers.

This anniversaryย gatheringย was more than just a celebrationโ€” itโ€™sย ๐—ฎย ๐—ต๐—ฒ๐—ฎ๐—ฟ๐˜๐—ณ๐—ฒ๐—น๐˜ย ๐˜๐—ต๐—ฎ๐—ป๐—ธย ๐˜†๐—ผ๐˜‚ ๐˜๐—ผย ๐—ฒ๐˜ƒ๐—ฒ๐—ฟ๐˜†๐—ผ๐—ป๐—ฒย ๐˜„๐—ต๐—ผย ๐—ต๐—ฎ๐˜€ย ๐˜„๐—ฎ๐—น๐—ธ๐—ฒ๐—ฑย ๐˜๐—ต๐—ถ๐˜€ย ๐—ท๐—ผ๐˜‚๐—ฟ๐—ป๐—ฒ๐˜†ย ๐˜„๐—ถ๐˜๐—ตย ๐˜‚๐˜€. From those whoโ€™ve been with us from day one to those whoโ€™ve joined from afar more recently, your support means the world to us.

Weโ€™re proud of how far weโ€™ve come, and weโ€™re even more excited about where weโ€™re headed. Together, weโ€™ll keep moving science forward.

Hereโ€™s to the next chapters of Gate2Brain โ€” with courage, collaboration, and care at the core.

๐—ง๐—ต๐—ฒย ๐—ฏ๐—ฒ๐˜€๐˜ย ๐—ถ๐˜€ย ๐˜†๐—ฒ๐˜ย ๐˜๐—ผย ๐—ฐ๐—ผ๐—บ๐—ฒ!

 

July 9, 2025/by noticias
Tags: 5th anniversary
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2025/07/5th-anniversary-G2B.png 380 520 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2025-07-09 18:07:312025-07-11 14:28:47๐—š๐—ฎ๐˜๐—ฒ๐Ÿฎ๐—•๐—ฟ๐—ฎ๐—ถ๐—ป ๐˜๐˜‚๐—ฟ๐—ป๐˜€ ๐Ÿฑ!

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categorรญa
  • Video Content

Events

  • Bioengineering the Future of Drug Deliveryย workshop – PortoApril 8, 2025 - 10:03
  • Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | BostonMarch 26, 2025 - 15:34
  • 4YFN 2025March 6, 2025 - 19:45
  • Keystone Symposia on Drug Delivery to the Brain: Emerging ModalitiesFebruary 21, 2025 - 11:10
  • Gate2Brain at ACCELERATE 2025: A Decade of Impact and Future Innovations in Pediatric OncologyFebruary 20, 2025 - 10:19

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
ยฉ Copyright โ€“Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Gate2Brain obtains FDA Orphan Drug Designation for G2B-002
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}